Daily Anesthesiology Research Analysis
Analyzed 29 papers and selected 3 impactful papers.
Summary
The strongest paper is a large multicenter randomized trial showing that video laryngoscopy improves first-pass tracheal intubation success over direct laryngoscopy during routine operating-room anesthesia. Two additional randomized trials provide clinically actionable dosing and drug-selection evidence: obese parturients require higher prophylactic norepinephrine infusion rates during spinal anesthesia for cesarean delivery, and intraoperative esketamine is non-inferior to dexmedetomidine for oxygenation during one-lung ventilation while improving early recovery scores.
Research Themes
- Airway management and first-pass intubation success
- Personalized hemodynamic management in obstetric anesthesia
- Drug selection and recovery during one-lung ventilation
Selected Articles
1. Conventional vs Video-Assisted Laryngoscopy for Perioperative Endotracheal Intubations: A Randomized Clinical Trial.
In the multicenter COVALENT randomized trial, 2423 patients were analyzed after assignment to direct laryngoscopy, video laryngoscopy with a Macintosh blade, or hyperangulated video laryngoscopy. First-pass success was 78.2% with direct laryngoscopy, 82.9% with Macintosh video laryngoscopy, and 87.6% with hyperangulated video laryngoscopy; both video techniques were superior to direct laryngoscopy.
Impact: This is a large, pragmatic, multicenter randomized trial directly addressing a common airway-management decision. Its findings support video laryngoscopy as the preferred first-line approach for routine operating-room intubation, particularly with hyperangulated devices.
Clinical Implications: Routine operating-room intubation services should consider video laryngoscopy as the default first-line technique, while maintaining competency in direct laryngoscopy and selecting blade geometry according to operator expertise, patient anatomy, and equipment availability.
Key Findings
- First-pass success was 78.2% with direct laryngoscopy, 82.9% with Macintosh video laryngoscopy, and 87.6% with hyperangulated video laryngoscopy.
- Both video laryngoscopy approaches were statistically superior to direct laryngoscopy for first-pass success.
- After failed first attempts, video laryngoscopy achieved positive capnography faster than direct laryngoscopy, and hyperangulated devices had fewer reported lip or dental injuries and blood on the blade.
Methodological Strengths
- Large three-arm randomized clinical trial conducted across six academic or intermediate-care centers.
- Use of multiple manufacturers and blade geometries improved real-world generalizability, and analyses followed a modified intention-to-treat approach.
Limitations
- Pregnant patients, planned fiberoptic intubations, and patients requiring non-general anesthesia were excluded, limiting applicability to those populations.
- The study was not designed to determine superiority in difficult-airway or emergency settings, and operator experience may have influenced device-specific performance.
Future Directions: Future trials should evaluate video laryngoscopy in anticipated and unanticipated difficult airways, emergency intubation, obese and pregnant populations, and resource-limited settings, while examining training requirements, cost-effectiveness, and patient-centered complications.
IMPORTANCE: Video laryngoscopy is increasingly used in routine tracheal intubation in the operating room, but evidence regarding its clinical outcomes remains inconclusive. In particular, the role of hyperangulated video laryngoscopes as first-choice devices has not been studied sufficiently. OBJECTIVE: To determine whether video laryngoscopy-regardless of blade geometry or manufacturer-provides superior first-pass success compared with direct laryngoscopy (DL) during routine tracheal intubations.
2. Esketamine versus dexmedetomidine for oxygenation and postoperative quality of recovery in thoracoscopic surgery: a randomized, double-blind, non-inferiority controlled trial.
In this prospective double-blind non-inferiority trial, 120 patients undergoing thoracoscopic surgery were analyzed. Esketamine was non-inferior to dexmedetomidine for the PaO2/FiO2 ratio after initiation of one-lung ventilation, while improving respiratory mechanics, reducing opioid requirements, and producing higher 24-hour Quality of Recovery-15 scores than control and dexmedetomidine.
Impact: The study provides comparative randomized evidence for an increasingly used anesthetic adjunct during one-lung ventilation. It identifies esketamine as a potential alternative that preserves oxygenation while improving early recovery, although pulmonary complication reduction was not demonstrated.
Clinical Implications: Esketamine may be considered as an intraoperative adjunct in thoracoscopic surgery when opioid sparing and early recovery are priorities. Its use should not be interpreted as a proven strategy for preventing postoperative pulmonary complications.
Key Findings
- Esketamine was non-inferior to dexmedetomidine for the PaO2/FiO2 ratio 60 minutes after one-lung ventilation began.
- Compared with control, esketamine improved intraoperative respiratory mechanics and reduced opioid requirements.
- Esketamine produced higher 24-hour Quality of Recovery-15 scores than both control and dexmedetomidine, but postoperative pulmonary complications did not differ significantly among groups.
Methodological Strengths
- Prospective randomized, double-blind, three-arm non-inferiority design with a physiologically relevant primary outcome.
- Use of linear mixed-effects models and evaluation of both respiratory physiology and patient-centered recovery outcomes.
Limitations
- The analyzed sample was modest, with 120 patients, which limits power for uncommon postoperative pulmonary complications.
- The trial evaluated short-term recovery and did not establish long-term functional benefits or superiority for major postoperative outcomes.
Future Directions: Larger pragmatic trials should evaluate optimal esketamine dosing, opioid-sparing protocols, long-term recovery, neuropsychiatric safety, and pulmonary outcomes in high-risk thoracic-surgery populations.
PURPOSE: One-lung ventilation (OLV) frequently induces hypoxemia. This study investigated whether intraoperative esketamine is non-inferior to dexmedetomidine in maintaining oxygenation during OLV and evaluated its impact on postoperative recovery. METHODS: In this prospective, double-blind, non-inferiority trial, 126 adults undergoing thoracoscopic surgery were randomized to saline (Control), dexmedetomidine, or esketamine.
3. Dose-response relationship of prophylactic norepinephrine infusion for prevention of spinal anesthesia-induced hypotension during caesarean delivery: A comparative study of normal weight and obese parturients.
This randomized, double-blind dose-response study enrolled 200 women undergoing elective cesarean delivery and compared norepinephrine infusion requirements by body-mass-index category. The ED50 and ED95 were 0.022 and 0.051 micrograms/kg/min in normal-weight women versus 0.036 and 0.080 micrograms/kg/min in obese women, with a relative potency ratio of 1.597.
Impact: The paper provides quantitative, clinically usable dose-response estimates for prophylactic norepinephrine during spinal anesthesia. It demonstrates that a single weight-adjusted regimen may underdose obese parturients, supporting individualized vasopressor protocols in obstetric anesthesia.
Clinical Implications: When using prophylactic norepinephrine during cesarean delivery under spinal anesthesia, clinicians should consider higher weight-adjusted infusion rates for obese parturients, with close blood-pressure and heart-rate monitoring and attention to neonatal and maternal safety.
Key Findings
- The norepinephrine ED50 was 0.022 micrograms/kg/min in normal-weight parturients and 0.036 micrograms/kg/min in obese parturients.
- The norepinephrine ED95 was 0.051 micrograms/kg/min in normal-weight parturients and 0.080 micrograms/kg/min in obese parturients.
- The relative potency ratio was 1.597, while neonatal outcomes and maternal adverse effects were comparable between groups.
Methodological Strengths
- Randomized, double-blind dose-response design with predefined ED50 and ED95 estimation.
- Direct comparison of normal-weight and obese parturients under standardized combined spinal-epidural anesthesia and a consistent hypotension definition.
Limitations
- The study used a limited range of norepinephrine infusion rates and may not define the optimal dose for extremely obese patients or other obstetric risk groups.
- The abstract does not provide detailed information on vasopressor rescue therapy, hemodynamic variability, or longer-term maternal and neonatal follow-up.
Future Directions: Future studies should validate body-size-adapted norepinephrine algorithms across broader BMI ranges, compare dosing strategies based on actual versus ideal body weight, and assess effects on maternal cardiac output, uteroplacental perfusion, and neonatal neurodevelopment.
Obese parturients are at increased risk of spinal anesthesia-induced hypotension during cesarean delivery, but optimal prophylactic norepinephrine dosing remains unclear. In this randomized, double-blind, dose-response study, 200 parturients undergoing elective cesarean delivery were stratified into obese (BMI ≥30 kg/m²) and normal weight (BMI 18.5-24.9 kg/m²) groups. Within each group, patients received norepinephrine infusion at 0.02 to 0.06 µg·kg⁻¹·min⁻¹.